Staff editor

The double-edged sword of dietary fiber: tailoring fiber intake for gut health in autoimmune conditions

Heather Armstrong, from University of Manitoba and University of Alberta (Canada), explores the intricate role of dietary fibers in maintaining gut health, focusing on the microbiome’s ability to process these…

Personalized nutrition in a changing world: addressing global health challenges with lifestyle medicine and omics

Hellas Cena, from University of Pavia (Italy), emphasizes the growing importance of nutrition in addressing current global health challenges.

MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the stage for future advances

A significant milestone for both microbiome research and neurodegenerative diseases.

Microbial signatures for food traceability: ensuring quality and safety from fermented wines to novel insect-based foods

The interview with Antonia Bruno, from Bicocca University of Milan (Italy), highlights research focused on using microbial signatures to enhance food traceability, ensuring both safety and quality. 

Freya Biosciences secures $10.4 million investment to tackle women’s health challenges

A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.

From Biofarma Group a probiotic therapy as an adjuvant to cancer immunotherapy

Biofarma Group has launched an innovative project in collaboration with the Department of Surgery, Endocrinology and Gastroenterology of the University of Naples ‘Federico II’, the Centro Sperimentale del Latte (CSL)…

QIAGEN and McGill University partner to drive innovation in microbiome research

Three-year collaboration to pioneer new insights in microbial sciences and health applications.

Dietary fiber, bloutia, and mucus function: uncovering potential for Next-Generation Probiotics

The interview with Björn O. Schröder from Umeå University explores groundbreaking research on the gut mucus layer, which shields intestinal tissues from bacterial invasion and inflammation.

EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis treatment

New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.

October 2024 review: M&A, licensing, and investments in one place

October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top